The new phantom manufactured by Pars Isotope Co. received approval from Imam Khomeini Hospital in Tehran.
Obtaining a bilingual GMP certificate from Iran Food and Drug Administration (IFDA) for the production lines of FDG radiopharmaceutical and the Pars-GalluGEN generator
The Administrator of Drug and Controlled Substances Affairs of the Food and Drug Organization Visited Pars Isotope Company.
Utilizing radiopharmaceuticals made by Pars Isotope Co. for the feasibility and investigation of the therapeutic potential of (Ga-68/Lu-177)-DOTATATE theranostic pair in patients with metastatic medullary thyroid carcinoma.